Publications by authors named "Richard Nowak"

Claim this Profile
T
Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology.
Alexandra C Bayer, Liliana M Sanmarco, Alex Pellerin, Gianvito Masi, Agustin Plasencia, Richard J Nowak

Proc Natl Acad Sci U S A· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgA autoantibodies demonstrate a novel mechanism of MuSK myasthenia gravis pathology.
Gianvito Masi, Kangzhi Chen, Alexandra C Bayer, Rafael Bayarri-Olmos, Minh C Pham, Richard J Nowak

Brain· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AChR Autoantibody Pathogenic Properties Are Heterogeneously Distributed and Undergo Temporal Changes Among Patients With Myasthenia Gravis.
Fatemeh Khani-Habibabadi, Bhaskar Roy, Minh C Pham, Abeer H Obaid, Beata Filipek, Richard J Nowak

Neurol Neuroimmunol Neuroinflamm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Distinct Immunological Signature in Late-Onset Myasthenia Gravis: Insights from an Exploratory Proteomics Study.
Bhaskar Roy, Jiaxin Chen, Fatemeh Khani-Habibabadi, Nilay McLaren, Betty C Soliven, Richard J Nowak

Ann Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Racial and Ethnic Disparities in Myasthenia Gravis Outcomes: EXPLORE-MG Registry Experience.
Nilay P McLaren, Bhaskar Roy, Richard J Nowak

Neurol Clin Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B Cell Tolerance and BCR Signaling Dysregulation in NF155-Mediated Autoimmune Nodopathies.
Bhaskar Roy, Abeer H Obaid, Zhenjian Wang, Kristof G Kovacs, Sarah Ohashi, Richard J Nowak

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of cellular immune dysregulation to myasthenia gravis pathology.
Alexandra C Bayer, Richard J Nowak, Kevin C O'Connor

Int Rev Neurobiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis.
Richard J Nowak, Michael Benatar, Emma Ciafaloni, James F Howard, M Isabel Leite

N Engl J Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and patient characteristics of the US myasthenia gravis population: real-world evidence from a large insurance claims database.
Lesley-Ann Miller-Wilson, Joel Arackal, Yuriy Edwards, Jennifer Schwinn, Kristen Elizabeth Rockstein, Richard J Nowak

BMJ Neurol Open· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Exacerbation and Level of Healthcare Resource Utilization in Myasthenia Gravis Assessed by Myasthenia Gravis Activities of Daily Living Score.
Angela Ting, Minjee Park, Oshin Sangha, Mohita Kumar, Jean-François Ricci, Richard J Nowak

Neurol Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CMT2 and distal hereditary motor neuropathy associated with VRK1 variants: Case series.
Sasha A Živković, Richard J Nowak, Daniel DiCapua

Neuromuscul Disord· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study.
Carlo Antozzi, Tuan Vu, Sindhu Ramchandren, Richard J Nowak, Constantine Farmakidis

Lancet Neurol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US Clinical Practice Experience with Eculizumab in Myasthenia Gravis: Acute Clinical Events and Healthcare Resource Utilization.
Richard J Nowak, Ali A Habib, Andrew J Klink, Srikanth Muppidi, Anju Parthan

Drugs Real World Outcomes· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of digital tools and artificial intelligence in the Myasthenia Gravis Core Examination.
Marc Garbey, Quentin Lesport, Helen Girma, Gülşen Öztosun, Mohammed Abu-Rub, Richard J Nowak

Front Neurol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigen-specific immune therapy (CNP-106) for treatment of generalised myasthenia gravis: rationale and design of first-in-human randomised controlled trial.
Samantha G Brew, Molly Frey, Derrick P McCarthy, Adam Elhofy, Richard J Nowak

BMJ Neurol Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescence-detection size-exclusion chromatography specifically detects autoantibodies targeting the ganglionic acetylcholine receptor in patients with autoimmune autonomic ganglionopathy.
Leah Baxter, Steven Hopkins, Kevin C O'Connor, Minh C Pham, Richard J Nowak

J Neuroimmunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
United States clinical practice experience with eculizumab in myasthenia gravis: symptoms, function, and immunosuppressant therapy use.
Ali A Habib, Andrew J Klink, Srikanth Muppidi, Anju Parthan, S Chloe Sader, Richard J Nowak

J Neurol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Digital Tools and Artificial Intelligence to the Myasthenia Gravis Core Examination.
Marc Garbey, Quentin Lesport, Helen Girma, Gülṣen Öztosen, Mohammed Abu-Rub, Richard Nowak

medRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling the proteome-wide autoreactome enables enhanced evaluation of emerging CAR T cell therapies in autoimmunity.
Aaron Bodansky, David Jl Yu, Alysa Rallistan, Muge Kalaycioglu, Jim Boonyaratanakornkit, Richard J Nowak

J Clin Invest· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.
James F Howard, Saskia Bresch, Constantine Farmakidis, Miriam Freimer, Angela Genge, Richard J Nowak

Ther Adv Neurol Disord· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Noncanonical CD56dimCD16dim/- NK Cell Subset Indicative of Prior Cytotoxic Activity Is Elevated in Patients with Autoantibody-Mediated Neurologic Diseases.
Soumya S Yandamuri, Beata Filipek, Nikhil Lele, Inessa Cohen, Jeffrey L Bennett, Richard J Nowak

J Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating the Observation Zone: Do Risk Scores Help Stratify Patients With Indeterminate High-Sensitivity Cardiac Troponins?
Nicklaus P Ashburn, James K McCord, Anna C Snavely, Robert H Christenson, Fred S Apple, Richard M Nowak

Circulation· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis: Results From the Randomized Phase 2 Vivacity-MG Study.
Carlo Antozzi, Jeffrey Guptill, Vera Bril, Josep Gamez, Sven G Meuth, Richard J Nowak

Neurology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial.
Michael Benatar, Heinz Wiendl, Richard Nowak, Yan Zheng, William Macias

BMJ Neurol Open· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling the autoreactome: Proteome-wide immunological fingerprints reveal the promise of plasma cell depleting therapy.
Aaron Bodansky, David Jl Yu, Alysa Rallistan, Muge Kalaycioglu, Jim Boonyaratanakornkit, Richard J Nowak

medRxiv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis